Intravascular tumor extension, also known as tumor thrombus, can occur in many different
types of cancer. Those with the highest proclivity include Wilm's tumor, renal cell carcinoma …

Hepatocellular carcinoma (HCC) is a major cause of cancer death and is increasing in
incidence. This review focuses on HCC surveillance and treatment of early-stage disease …

Abstract Background Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is an
efficient biomarker specific for hepatocellular carcinoma (HCC). Some researchers have …

High rates of glucose transport via solute carrier (SLC2A, GLUT) family members are
required to satisfy the high metabolic demands of cancer cells, and because of this …

Background: Tumoral macrovascular invasion (MVI) of hepatic and/or portal vein branches
is a common phenomenon in hepatocellular carcinoma (HCC) and is associated with poorer …

Hepatocellular carcinoma (HCC) is the fourth most common and the third most lethal cancer
in China. An updated version of consensus-based recommendations on the management of …

Purpose To test the hypothesis that prophylactic administration of dexamethasone alleviates
postembolization syndrome (PES) after transarterial chemoembolization for the treatment of …

Hepatocellular carcinomas (HCCs) exhibit a diversity of molecular phenotypes, raising
major challenges in clinical management. HCCs detected by surveillance programs at an …

Background & aims Hypothyroidism has recently been proposed as predisposing factor for
HCC development. However, the role of thyroid hormones (TH) in established HCC is …

Purpose To analyze long-term outcomes in patients bridged/downstaged to orthotopic liver
transplantation (OLT) by transarterial chemoembolization (TACE) or yttrium-90 …